We are live on ! Find out more
IMTXW

Immatics N.V. Warrants
IMTXW

Delisted

IMTXW was delisted on the 30th of June, 2025.

Back to rankings

19 hedge funds and large institutions have $19.5M invested in Immatics N.V. Warrants in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

9.55% more ownership

Funds ownership: 0% → 9.55% (+9.6%)

0% more funds holding

Funds holding: 19 → 19 (0)

11% less capital invested

Capital invested by funds: $21.9M → $19.5M (-$2.36M)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
6
Closed
2
Calls
$66K
Puts
–
Net Calls
+$66K
Net Calls Change
+$66K

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$2.23M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$655K
3
JFG
Jefferies Financial Group
New York
+$104K
4
VF
Virtu Financial
New York
+$34.1K

Top Sellers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
-$1.08M
2
Walleye Capital
Walleye Capital
New York
-$424K
3
LP
LMR Partners
United Kingdom
-$409K
4
6CM
683 Capital Management
New York
-$107K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$68.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$4.76M -$409K -134,516 -20%
NCM
2
Nantahala Capital Management
Connecticut
$2.48M -$4.05K -1,331 -0.1%
FBCM
3
Fort Baker Capital Management
California
$2.2M -$13.4K -4,400 -0.5%
AC
4
Aristeia Capital
Connecticut
$1.86M +$2.23M +732,354 +3,294%
Walleye Capital
5
Walleye Capital
New York
$1.25M -$424K -139,292 -22%
DCM
6
Difesa Capital Management
New York
$1.18M – – –
6CM
7
683 Capital Management
New York
$1.17M -$107K -35,064 -7%
GL
8
Governors Lane
New York
$1.15M – – –
JP Morgan Chase
9
JP Morgan Chase
New York
$849K – – –
AAI
10
Aequim Alternative Investments
California
$634K – – –
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$529K +$655K +215,223 New
AAA
12
Affinity Asset Advisors
New York
$470K – – –
SFM
13
Sphera Funds Management
Israel
$251K – – –
AGC
14
Angelo Gordon & Co
New York
$218K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$166K -$68.5K -22,525 -25%
BFM
16
Boothbay Fund Management
New York
$115K – – –
JFG
17
Jefferies Financial Group
New York
$80.3K +$104K +34,158 New
SSA
18
Schonfeld Strategic Advisors
New York
$63.4K – – –
WAM
19
Weiss Asset Management
Massachusetts
$53.7K – – –
VF
20
Virtu Financial
New York
$28K +$34.1K +11,202 New
ICM
21
Ionic Capital Management
New York
– -$1.08M -399,683 Closed
UBS Group
22
UBS Group
Switzerland
– -$1K -232 Closed

IMTXW Hedge Fund Activity: Q4 2022 in Review

19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immatics N.V. Warrants (IMTXW) for Q4 2022, worth a combined $19.5M — down 11% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IMTXW positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 6 trimmed.

The largest buyer was Aristeia Capital, adding an estimated $2.23M. The largest seller was Ionic Capital Management, exiting entirely with an estimated $1.08M sold.

  • 19 institutional investors held Immatics N.V. Warrants (IMTXW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $19.5M of Immatics N.V. Warrants stock for Q4 2022, down 11% quarter-over-quarter.
  • 3 funds opened new Immatics N.V. Warrants positions in Q4 2022 and 2 closed out, a net change of +1 holder.
  • The largest Immatics N.V. Warrants buyer in Q4 2022 was Aristeia Capital, an estimated $2.23M added.
  • The largest Immatics N.V. Warrants seller in Q4 2022 was Ionic Capital Management, an estimated $1.08M sold.

Based on aggregated 13F filings for Q4 2022.